INT297359

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.19
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.62
Pain Relevance 0.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (LPL) small molecule metabolic process (LPL) extracellular region (LPL)
plasma membrane (LPL) lipid metabolic process (LPL)
LPL (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammatory response 5 56.56 Quite High
Inflammation 7 31.44 Quite Low
agonist 33 5.00 Very Low Very Low Very Low
cINOD 7 5.00 Very Low Very Low Very Low
antagonist 2 5.00 Very Low Very Low Very Low
methotrexate 1 5.00 Very Low Very Low Very Low
withdrawal 1 5.00 Very Low Very Low Very Low
headache 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Obesity 17 98.96 Very High Very High Very High
Targeted Disruption 3 88.28 High High
INFLAMMATION 12 56.20 Quite High
Aging 2 47.68 Quite Low
Apoptosis 20 33.32 Quite Low
Increased Venous Pressure Under Development 3 30.88 Quite Low
Syndrome 1 20.72 Low Low
Osteoporosis 17 20.16 Low Low
Congenital Anomalies 2 19.92 Low Low
Dyslipidemia /

Combined Dyslipidemia

1 16.76 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
include LPL and fatty acid transporter FATP in stimulating fatty acid uptake, malic enzyme in NADPH synthesis for lipogenesis, phosphoenolpyruvate carboxykinase in gluconeogenesis, and ACS in FA esterification [16, 80–82].
Phosphorylation (phosphoenolpyruvate) of LPL
1) Confidence 0.19 Published 2010 Journal PPAR Research Section Body Doc Link PMC2825651 Disease Relevance 0.62 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox